Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

Journal of Neurochemistry

Volumn 73, Issue 6, 1999, Pages 2485-2490

  Wiltfang, J ^a   Otto, M ^a   Baxter, H C ^b   Bodemer, M ^a   Steinacker, P ^a   Bahn, E ^a   Zerr, I ^a   Kornhuber, J ^a   Kretzschmar, H A ^a   Poser, S ^a   Ruther E ^a   Aitken, A ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

14 3 3 proteins; Alzheimer's disease; Cerebrospinal fluid; Creutzfeldt Jakob disease; Isoform specific antibodies

Indexed keywords

BRAIN PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC APPROACH ROUTE; DISEASE MARKER; FEMALE; HERPES SIMPLEX ENCEPHALITIS; HUMAN; MALE; NERVE DEGENERATION; NEUROCHEMISTRY; PRIORITY JOURNAL;

14-3-3 PROTEINS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CEREBROSPINAL FLUID PROTEINS; CREUTZFELDT-JAKOB SYNDROME; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; PROTEINS; TYROSINE 3-MONOOXYGENASE;

HERPES;

EID: 0032750754     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0732485.x     Document Type: Article

References (38)

1. Aitken A. (1995) 14-3-3 proteins on the MAP. Trends Biochem. Sci. 20, 95-97.
2. Aitken A. (1996) 14-3-3 and its possible role in coordinating multiple signalling pathways. Trends Cell Biol. 6, 341-347.
3. Aitken A., Collinge D. B., van Heusden B. P., Isobe T., Roseboom P. H., Rosenfeld G., and Soll J. (1992) 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins. Trends Biochem. Sci. 17, 498-501.
4. Aitken A., Howell S., Jones D., Madrazo J., Martin H., Patel Y., and Robinson K. (1995) Post-translationally modified 14-3-3 isoforms and inhibition of protein kinase C. Mol. Cell. Biochem. 149, 41-49.
5. Alperovitch A., Brown P., Weber T., Pocchiari M., Hofman A., and Will R. (1994) Incidence of Creutzfeldt-Jakob disease in Europe in 1993. Lancet 343, 918.
6. Brown P., Gibbs C. J. Jr., Rodgers-Johnson P., Asher D. M., Sulima M. P., Bacote A., Goldfarb L. G., and Gajdusek D. C. (1994) Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol. 35, 513-529.
7. Chazot G., Broussolle E., Lapras C., Blattler T., Aguzzi A., and Kopp N. (1996) New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 347, 1181.
8. Harrington M. G., Merril C. R., Asher D. M., and Gajdusek D. C. (1986) Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N. Engl. J. Med 315, 279-283.
9. Hill A. F., Butterworth R. J., Joiner S., Jackson G., Rossor M. N., Thomas D. J., Frosh A., Tolley N., Bell J. E., Spencer M., King A., Al-Sarraj S., Ironside J. W., Lantos P. L., and Collinge J. (1999) Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353, 183-189.
10. Hsich G., Kenney K., Gibbs C. J., Lee K. H., and Harrington M. G. (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 335, 924-930.
11. Ironside J. W., Sutherland K., Bell J. E., McCardle L., Barrie C., Estebeiro K., Zeidler M., and Will R. G. (1996) A new variant of Creutzfeldt-Jakob disease: neuropathological and clinical features. Cold Spring Harbor Symp. Quant. Biol. 61, 523-530.
12. Kretzschmar H. A., Ironside J. W., DeArmond S. J., and Tateishi J. (1996) Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch. Neurol. 53, 913-920.
13. Laemmli U. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
14. Lasa M., Howell S., Cochon A. C., Dubois T., and Aitken A. (1999) 14-3-3 gamma stimulates histone H4 phosphorylation in brain Golgi: involvement of protein kinase C epsilon. J. Biol. Chem. (in press).
15. Layfield R., Fergusson J., Aitken A., Lowe J., Landon M., and Mayer R. J. (1996) Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins. Neurosci. Lett. 209, 57-60.
16. Lee K. H. and Harrington M. G. (1997) The assay development of a molecular marker for transmissible spongiform encephalopathies. Electrophoresis 18, 502-506.
17. Leffers H., Madsen P., Rasmussen H. H., Honore B., Andersen A. H., Walbum E., Vandekerckhove J., and Celis J. E. (1993) Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway. J. Mol. Biol. 231, 982-998.
18. Martin H., Patel Y., Jones D., Howell S., Robinson K., and Aitken A. (1993) Antibodies against the major brain isoforms of 14-3-3 protein. An antibody specific for the N-acetylated amino-terminus of a protein. FEBS Lett. 331, 296-303.
19. Martin H., Rostas J., Patel Y., and Aitken A. (1994) Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies. J. Neurochem. 63, 2259-2265.
20. Masters C. L., Harris J. O., Gajdusek D. C., Gibbs C. J. Jr., Bernoulli C., and Asher D. M. (1979) Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann. Neurol. 5, 177-188.
21. McKhann G., Drachman D., Folstein M., Kalzman R., Price D., and Stadlan E. M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
22. Oesch B., Westaway D., Walchli M., McKinley M. P., Kent S. B., Aebersold R., Barry R. A., Tempst P., Teplow D. B., Hood L. E., et al. (1985) A cellular gene encodes scrapie PrP 27-30 protein. Cell 40, 735-746.
23. Otto M., Stein H., Szudra A., Zerr I., Bodemer M., Gefeller O., Poser S., Kretzschmar H. A., Mader M., and Weber T. (1997a) S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J. Neurol. 244, 566-570.
24. Otto M., Wiltfang J., Tumani H., Zerr I., Lantsch M., Kornhuber J., Weber T., Kretzschmar H. A., and Poser S. (1997b) Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci. Lett. 225, 210-212.
25. Otto M., Wiltfang J., Schütz E., Zerr I., Otto A., Pfahlberg A., Gefeller O., Uhr M., Giese A., Weber T., Kretzschmar H. A., and Poser S. (1998) Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study. Br. Med. J. 316, 577-582.
26. Patel Y., Martin H., Howell S., Jones D., Robinson K., and Aitken A. (1994) Purification of 14-3-3 protein and analysis of isoforms in chicken brain. Biochim. Biophys. Acta 1222, 405-409.
27. Pietromonaco S. F., Seluja G. A., Aitken A., and Elias L. (1996) Association of 14-3-3 proteins with centrosomes. Blood Cells Mol. Dis. 22, 225-237.
28. Prusiner S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144.
29. Robey W. G., Jackson R., Walters R. L., Brackett J. M., Harrington C. A., and Killian W. R. (1998) Use of cerebrospinal fluid levels of 14-3-3 in predicting neurodegeneration in confirmed BSE symptomatic cattle. Vet. Rec. 143, 50-51.
30. Tagliavini F., Prelli F., Porro M., Salmona M., Bugiani O., and Frangione B. (1992) A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem. Biophys. Res. Commun. 184, 1398-1404.
31. Toker A., Ellis C. A., Sellers L. A., and Aitken A. (1990) Protein kinase C inhibitor proteins. Purification from sheep brain and sequence similarity to lipocortins and 14-3-3 protein. Eur. J. Biochem. 191, 421-429.
32. Will R. G. (1993) Epidemiology of Creutzfeldt-Jakob disease. Br. Med. Bull. 49, 960-970.
33. Will R. G., Ironside J. W., Zeidler M., Cousens S. N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofman A., and Smith P. G. (1996a) A new variant of Creutzfeldt-Jakob disease in the U.K. Lancet 347, 921-925.
34. Will R. G., Zeidler M., Brown P., Harrington M., Lee K. H., and Kenney K. L. (1996b) Cerebrospinal-fluid test for new-variant Creutzfeldt-Jakob disease. Lancet 348, 955.
35. Zeidler M., Stewart G. E., Barraclough C. R., Bateman D. E., Bates D., Burn D. J., Colchester A. C., Durward W., Fletcher N. A., Hawkins S. A., Mackenzie J. M., and Will R. G. (1997) New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet 350, 903-907.
36. Zerr I., Bodemer M., Racker S., Grosche S., Poser S., Kretzschmar H. A., and Weber T. (1995) Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 345, 1609-1610.
37. Zerr I., Bodemer M., Otto M., Poser S., Windl O., Kretzschmar H. A., Gefeller O., and Weber T. (1996) Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet 348, 846-849.
38. Zerr I., Bodemer M., Gefeller O., Otto M., Poser S., Wiltfang J., Windl O., Kretzschmar H. A., and Weber T. (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann. Neurol. 43, 32-40.